Genome Editing in Apicomplexan Parasites: Current Status, Challenges, and Future Possibilities

Area of Science:

• Molecular Biology
• Genetics
• Parasitology

Background:

• Clustered regularly interspaced short palindromic repeats (CRISPR)-CRISPR-associated protein (Cas) technology has emerged as a powerful tool for genome editing.
• Apicomplexa, a phylum of parasitic protozoa, includes significant human and animal pathogens like Plasmodium, Toxoplasma, Theileria, Babesia, and Cryptosporidium.
• The application of CRISPR-Cas9 in these parasites is crucial for understanding their biology and developing novel control strategies.

Purpose of the Study:

• To review the current status, challenges, and applications of CRISPR-Cas9 genome editing technology in apicomplexan parasites.
• To highlight successful CRISPR-Cas9 implementations and their impact on apicomplexan research.
• To discuss future perspectives and ethical considerations of CRISPR-Cas applications in this phylum.

Main Methods:

• Comprehensive literature review of studies utilizing CRISPR-Cas9 in apicomplexan parasites.
• Analysis of successful gene modification strategies and genome-wide screening approaches.
• Identification and discussion of technical and biological challenges specific to apicomplexan genome editing.

Main Results:

• CRISPR-Cas9 has been successfully applied for precise gene editing in various apicomplexan species, including Plasmodium and Toxoplasma.
• Milestones achieved include targeted gene knockouts, modifications, and large-scale genetic screens.
• Significant challenges persist, such as complex life cycles, intracellular stages, and limited genetic tools.

Conclusions:

• CRISPR-Cas9 technology offers unprecedented opportunities for functional genomics in apicomplexan parasites.
• Overcoming existing challenges is essential for maximizing the potential of CRISPR-Cas9 in this field.
• Ethical considerations and future advancements will shape the trajectory of genome editing applications in apicomplexan research.